{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:20:43Z","timestamp":1789676443250,"version":"4.0.1"},"reference-count":43,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Liver disease results in complex alterations of all 3 phases of hemostasis. It is now recognized that hemostasis is rebalanced in chronic liver disease. The fall in clotting factor levels is accompanied by a parallel fall in anticoagulant proteins. High von Willebrand factor levels counteract defects in primary hemostasis. Conventional coagulation tests do not fully reflect the derangement in hemostasis and do not accurately predict the risk of bleeding. Global coagulation assays (thrombin generation, thromboelastography) reflect the interaction between procoagulant factors, anticoagulant factors, platelets, and the fibrinolytic system and show promise for assessing bleeding risk and guiding therapy. These assays are not yet commercially approved or validated. Prevention of bleeding should not be aimed at correcting conventional coagulation tests. Thrombopoietin receptor agonists were shown to increase the platelet count in cirrhotic patients undergoing invasive procedures but may increase the risk of thrombosis. Rebalanced hemostasis in liver disease is precarious and may be tipped toward hemorrhage or thrombosis depending on coexisting circumstantial risk factors. Bacterial infection may impair hemostasis in cirrhosis by triggering the release of endogenous heparinoids. There are no evidence-based guidelines for hemostatic therapy of acute hemorrhage in liver disease. There is currently inadequate evidence to support the use of recombinant FVIIa, prothrombin complex concentrates, or tranexamic acid in acute variceal or other hemorrhage.<\/jats:p>","DOI":"10.1182\/asheducation-2015.1.243","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T15:23:25Z","timestamp":1473953005000},"page":"243-249","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":128,"title":["Coagulopathy in liver disease: a balancing act"],"prefix":"10.1182","volume":"2015","author":[{"given":"Jody L.","family":"Kujovich","sequence":"first","affiliation":[{"name":"Oregon Health & Science University, Pediatric Hematology\/Oncology, Oregon Hemophilia Center, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2019111702461124700_B1","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jhep.2010.08.018","article-title":"Platelet production and destruction in liver cirrhosis","volume":"54","author":"Pradella","year":"2011","journal-title":"J Hepatol"},{"issue":"2","key":"2019111702461124700_B2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: the role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"2019111702461124700_B3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"issue":"10","key":"2019111702461124700_B4","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1478-3231.2011.02617.x","article-title":"NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation","volume":"31","author":"Basili","year":"2011","journal-title":"Liver Int"},{"issue":"24","key":"2019111702461124700_B5","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1182\/blood-2014-02-554501","article-title":"Murine coagulation factor VIII is synthesized in endothelial cells","volume":"123","author":"Everett","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2019111702461124700_B6","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"2019111702461124700_B7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111702461124700_B8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2141.2009.08021.x","article-title":"Haemostasis and thrombosis in liver disease","volume":"148","author":"Roberts","year":"2010","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111702461124700_B9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jhep.2013.03.036","article-title":"Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis","volume":"59","author":"Tripodi","year":"2013","journal-title":"J Hepatol"},{"issue":"6","key":"2019111702461124700_B10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjh.12462","article-title":"Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels","volume":"162","author":"Potze","year":"2013","journal-title":"Br J Haematol"},{"issue":"10","key":"2019111702461124700_B11","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/j.1538-7836.2012.04901.x","article-title":"Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests","volume":"10","author":"Rijken","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2019111702461124700_B12","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1111\/j.1572-0241.2000.03299.x","article-title":"Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease","volume":"95","author":"Agarwal","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2019111702461124700_B13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"2019111702461124700_B14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1872-034X.2011.00950.x","article-title":"ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score","volume":"42","author":"Takaya","year":"2012","journal-title":"Hepatol Res"},{"issue":"1","key":"2019111702461124700_B15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/gast.2001.25481","article-title":"Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis","volume":"121","author":"Lisman","year":"2001","journal-title":"Gastroenterology"},{"issue":"6","key":"2019111702461124700_B16","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1538-7836.2010.03877.x","article-title":"Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease","volume":"8","author":"Tripodi","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2019111702461124700_B17","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1007\/s00464-012-2334-0","article-title":"The risk of postpolypectomy bleeding during colonoscopy in patients with early liver cirrhosis","volume":"26","author":"Jeon","year":"2012","journal-title":"Surg Endosc"},{"issue":"7","key":"2019111702461124700_B18","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.amjcard.2012.05.043","article-title":"Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization","volume":"110","author":"Townsend","year":"2012","journal-title":"Am J Cardiol"},{"issue":"9","key":"2019111702461124700_B19","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1537-2995.2005.00546.x","article-title":"Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review","volume":"45","author":"Segal","year":"2005","journal-title":"Transfusion"},{"issue":"3","key":"2019111702461124700_B20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"American Association for the Study of Liver D. Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"issue":"10","key":"2019111702461124700_B21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cgh.2010.06.018","article-title":"Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease","volume":"8","author":"Giannini","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"2019111702461124700_B22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/liv.12158","article-title":"Clinical utility of viscoelastic tests of coagulation in patients with liver disease","volume":"33","author":"Mallett","year":"2013","journal-title":"Liver Int"},{"issue":"9","key":"2019111702461124700_B23","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/j.1538-7836.2010.03937.x","article-title":"Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy","volume":"8","author":"Gatt","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2019111702461124700_B24","first-page":"513","article-title":"Potential applications of thromboelastography in patients with acute and chronic liver disease","volume":"8","author":"Stravitz","year":"2012","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"1","key":"2019111702461124700_B25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.thromres.2008.11.008","article-title":"The coagulopathy of cirrhosis assessed by thromboelastometry and its correlation with conventional coagulation parameters","volume":"124","author":"Tripodi","year":"2009","journal-title":"Thromb Res"},{"issue":"10","key":"2019111702461124700_B26","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/jth.12706","article-title":"Cirrhosis patients have a coagulopathy that is associated with decreased clot formation capacity","volume":"12","author":"Kleinegris","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111702461124700_B27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/gut.43.2.267","article-title":"Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding","volume":"43","author":"Chau","year":"1998","journal-title":"Gut"},{"issue":"1","key":"2019111702461124700_B28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MBC.0b013e32835975ed","article-title":"The coagulopathy of liver disease: does vitamin K help?","volume":"24","author":"Saja","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"2019111702461124700_B29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11739-011-0528-4","article-title":"Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma","volume":"7","author":"Tripodi","year":"2012","journal-title":"Intern Emerg Med"},{"issue":"1","key":"2019111702461124700_B30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.joms.2009.07.081","article-title":"Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial","volume":"68","author":"Stanca","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"2019111702461124700_B31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/liv.12038","article-title":"Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion","volume":"33","author":"Tripodi","year":"2013","journal-title":"Liver Int"},{"issue":"2","key":"2019111702461124700_B32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1440-1746.2012.07246.x","article-title":"Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis","volume":"28","author":"Moussa","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"2019111702461124700_B33","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa1110709","article-title":"Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia","volume":"367","author":"Afdhal","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111702461124700_B34","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jhep.2014.07.007","article-title":"Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure","volume":"61","author":"Terrault","year":"2014","journal-title":"J Hepatol"},{"key":"2019111702461124700_B35","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2015-309262","article-title":"UK guidelines on the management of variceal haemorrhage in cirrhotic patients","author":"Tripathi","year":"2015","journal-title":"Gut"},{"issue":"4","key":"2019111702461124700_B36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0168-8278(02)00208-8","article-title":"Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study","volume":"37","author":"Montalto","year":"2002","journal-title":"J Hepatol"},{"issue":"9","key":"2019111702461124700_B37","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1080\/00365520410004433","article-title":"Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and non-cirrhotic patients","volume":"39","author":"Zambruni","year":"2004","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"2019111702461124700_B38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.15403\/jgld.2014.1121.232.cht1","article-title":"Endogenous heparinoids detected by anti-Xa activity are present in blood during acute variceal bleeding in cirrhosis: a prospective study","volume":"23","author":"Triantos","year":"2014","journal-title":"J Gastrointestin Liver Dis"},{"issue":"1","key":"2019111702461124700_B39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111702461124700_B40","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/hep.22216","article-title":"Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial","volume":"47","author":"Bosch","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"2019111702461124700_B41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2014.03.035","article-title":"Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: an individual patient based meta-analysis of two controlled trials","volume":"61","author":"Bendtsen","year":"2014","journal-title":"J Hepatol"},{"key":"2019111702461124700_B42","first-page":"CD004887","article-title":"Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases","volume":"3","author":"Marti-Carvajal","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"2019111702461124700_B43","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/liv.12765","article-title":"Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis","volume":"35","author":"Arshad","year":"2014","journal-title":"Liver Int"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2015\/1\/243\/1250609\/bep00115000243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2015\/1\/243\/1250609\/bep00115000243.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T07:46:40Z","timestamp":1573976800000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2015\/1\/243\/20682\/Coagulopathy-in-liver-disease-a-balancing-act"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,5]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12,5]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2015.1.243","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,5]]}}}